KPTI7:30 AMKaryopharm to Participate at the 2026 Jefferies Global Healthcare Conferencekaryopharm.com
KPTI7:30 AMKaryopharm Reports First Quarter 2026 Financial Results and Completion of Phase 3 Endometrial Cancer Trial EnrollmentEnrollment • Phase 3Enrollment completion Thu, May 14, 2026karyopharm.com
KPTI10:32 AMKaryopharm's Phase 3 SENTRY Trial in Myelofibrosis Selected for Late-Breaking Oral Presentation at ASCO 2026 Annual MeetingPresentation / Abstract • Phase 3karyopharm.com
KPTI7:00 AMKaryopharm's Phase 3 SENTRY Trial in Myelofibrosis Met First Co-Primary Endpoint, Demonstrating Statistically Significant Improvement in Spleen Volume ReductionTrial Results • Phase 3karyopharm.com
KPTI4:05 PMKaryopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)karyopharm.com